Determination of Sex 43, Elm Park Gardens, THOSE Who Are Interested in the Heredity of Sex Chelsea, S.W.Lo

Total Page:16

File Type:pdf, Size:1020Kb

Determination of Sex 43, Elm Park Gardens, THOSE Who Are Interested in the Heredity of Sex Chelsea, S.W.Lo APRIL 14, 1934 NATURE 579 sa was correctly computed in five minutes, 510 in genes outweigh the female and the result is the twenty seconds and 610 in seventy seconds. normal haplo-X male." Division was a slower process and 9 digits divided Thus, as my italics show, the experimental by 3 took times varying from two and a half to geneticist seems to agree with what Prof. MacBride seven and three quarters minutes. has expressed in more generally intelligible language ; Square roots of 6 digit numbers were extracted in not only in admitting the essential sameness of sex less than a minute while cube roots took longer. in all organisms but also in understanding the Curiously enough, the memorising of a number of function of proportion in its determination in some 27 digits was not done successfully, although he of them. Unanimity among the different branches of could repeat questions which had been put to him biology has therefore been reached after a long period and their answers after some days had elapsed, and of divergence, from entirely different data and, what would break off calculations in the middle to ask for is more, apparently unawares. Such an event, surely, milk or cigarettes, taking up the calculations again should not be allowed to pass without notice and where he had broken off. His methods of working without applause. The usual view that the chromo­ were not discovered, but he had obviously memorised some theory of sex determination criticised by the squares of two digit numbers, and less completely MacBride was a special hypothesis put forward by the products of two digit numbers. McClung in 19024 and therefore not attributable to Though the arithmetical powers of this boy were Morgan, who accepted the hypothesis only in 191P, surprising, they were not comparable with those of should perhaps also not pass without mention. some of the calculating prodigies described by Rouse c. D. Ball in "Mathematical Recreations and Essays". John Innes Horticultural Institution, The boy was a good illustration of cases of arrest London, S.W.19. of mental development in which normal or even March 14. phenomenal mental capacity is observed in certain limited directions such as memory, calculating 1 NATURE, 133, 359, March 10, 1934. ' Qunrt. Rev. Biol., 6, 127 ; 1931. ability, musical ability, etc. He was so defective 'Amer. Nat., 56, 59; 1922. in respect to other mental faculties that he was ' Biol. BuU., 3, 43-74; 1902. • Science, N.S., 32, 839; 1911. unable to adjust himself to ordinary conditions of life, and became an inmate of the mental hospital. He died in the hospital at nineteen years of age. The autopsy disclosed that he had a softened patch, I AM delighted to find that such a distinguished probably an old hremorrhage, in the right occipital cytologist as Dr. Darlington "Though a long compass region of the brain, about the size of a small hen's round be fetched" has arrived at somewhat similar egg. A recent hremorrhage at the same place of the conclusions to those to which I myself have been led brain was the cause of his death. respecting the nature of sex. I do not, of course, H. W. DunGEON. view the 'gene' in the same light as he does, but H. E. HURST. Rince in an article shortly to be published in NATURE Cairo. I have given my views aR to the nature of the gene, Feb. 24. Dr. Darlington and I need not quarrel about the matter now. E. W. MAcBRIDE. Determination of Sex 43, Elm Park Gardens, THOSE who are interested in the heredity of sex Chelsea, S.W.lO. will be grateful to Prof. MacBride for again exposing March 17. in these columns' the naivete of some early views of this problem (which he attributes to Morgan). Especially will they be reassured by his conclusion. Ergine He points out that sex is essentially the same thing RECENTLY we showed' that the four ergot alkaloids wherever it occurs. He concludes :-"It seems clear (ergotoxine, ergotinine, ergotamine and ergotaminine) that there are fundamentally opposed male and by trAatment with alcoholic potassium hydroxide female constitutions, but that the constitution of give rise to a crystalline base ergine, which con­ every individual is a mixture of the two, and that stitutes about half the parent molecule. the structural manifestations of sex depend on the We have since proved that ergine is the amide proportion of these constitutions and on which gains of an acid, C 15H 15N 2 .COOE:, and further analyses of the upper hand in development" (italics mine). ergine and its salts show that the formula for ergine This view is somewhat similar to that reached by requires correction to C,.H170N 3 in agreement with way of experimental genetics. Thus Goldschmidt, the formula for the acid now isolated. reviewing his experiments since 19102 , states that Jacobs and Craig have published a paper2, in which "the resulting sex is dependent upon two genetic they have described the action of alkali upon ergotinine , somethings, one of which shifts sex towards the and the isolation of a crystalline acid, C 18H 160 2N 2 female, the other towards the male side". Again, which they name lysergic acid. We have no doubt Morgan's colleague Bridges3 says that "both sexes that this is identical with that prepared by ourselves are due to the action of opposed sets of genes, one from ergine. set tending to produce the characters called female, s. SMITH. and the other to produce the characters called male. G. M. TIMMIS. These two sets of genes are not equally effective, for W ellcome Chemical Works, in the complement as a whole the female-tendency Dartford, genes outweigh the male-tendency genes and the Kent. diploid (or triploid) form is a female. When the March 27. relative number of the female-tendency genes is 1 J. Chem. Soc., 1543; 1932. lowered by the absence of one X, the male-tendency 'J. Bwl. Ohem., 104, 547; 1934. © 1934 Nature Publishing Group.
Recommended publications
  • Headshop Highs & Lows
    HeadshopHeadshop HighsHighs && LowsLows AA PresentationPresentation byby DrDr DesDes CorriganCorrigan HeadshopsHeadshops A.K.A.A.K.A. ““SmartSmart ShopsShops””,, ““HempHemp ShopsShops””,, ““HemporiaHemporia”” oror ““GrowshopsGrowshops”” RetailRetail oror OnlineOnline OutletsOutlets sellingselling PsychoactivePsychoactive Plants,Plants, ‘‘LegalLegal’’ && ““HerbalHerbal”” HighsHighs asas wellwell asas DrugDrug ParaphernaliaParaphernalia includingincluding CannabisCannabis growinggrowing equipment.equipment. Headshops supply Cannabis Paraphernalia HeadshopsHeadshops && SkunkSkunk--typetype (( HighHigh Strength)Strength) CannabisCannabis 1.1. SaleSale ofof SkunkSkunk--typetype seedsseeds 2.2. AdviceAdvice onon SinsemillaSinsemilla TechniqueTechnique 3.3. SaleSale ofof HydroponicsHydroponics && IntenseIntense LightingLighting .. CannabisCannabis PotencyPotency expressedexpressed asas %% THCTHC ContentContent ¾¾ IrelandIreland ¾¾ HerbHerb 6%6% HashHash 4%4% ¾¾ UKUK ¾¾ HerbHerb** 1212--18%18% HashHash 3.4%3.4% ¾¾ NetherlandsNetherlands ¾¾ HerbHerb** 20%20% HashHash 37%37% * Skunk-type SkunkSkunk--TypeType CannabisCannabis && PsychosisPsychosis ¾¾ComparedCompared toto HashHash smokingsmoking controlscontrols ¾¾ SkunkSkunk useuse -- 77 xx riskrisk ¾¾ DailyDaily SkunkSkunk useuse -- 1212 xx riskrisk ¾¾ DiDi FortiForti etet alal .. Br.Br. J.J. PsychiatryPsychiatry 20092009 CannabinoidsCannabinoids ¾¾ PhytoCannabinoidsPhytoCannabinoids-- onlyonly inin CannabisCannabis plantsplants ¾¾ EndocannabinoidsEndocannabinoids –– naturallynaturally occurringoccurring
    [Show full text]
  • WO 2010/099522 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 2 September 2010 (02.09.2010) WO 2010/099522 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 45/06 (2006.01) A61K 31/4164 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 31/4045 (2006.01) A61K 31/00 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2010/025725 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 1 March 2010 (01 .03.2010) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/156,129 27 February 2009 (27.02.2009) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (71) Applicant (for all designated States except US): ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, HELSINN THERAPEUTICS (U.S.), INC.
    [Show full text]
  • LSD), Which Produces Illicit Market in the USA
    DEPENDENCE LIABILITY OF "NON-NARCOTIC 9 DRUGS 81 INDOLES The prototype drug in this subgroup (Table XVI) potentials. Ibogaine (S 212) has appeared in the is compound S 219, lysergide (LSD), which produces illicit market in the USA. dependence of the hallucinogen (LSD) type (see above). A tremendous literature on LSD exists which documents fully the dangers of abuse, which REFERENCES is now widespread in the USA, Canada, the United 304. Sandoz Pharmaceuticals Bibliography on Psychoto- Kingdom, Australia and many western European mimetics (1943-1966). Reprinted by the US countries (for references see Table XVI). LSD must Department of Health, Education, & Welfare, be judged as a very dangerous substance which has National Institute of Mental Health, Washington, no established therapeutic use. D.C. 305. Cerletti, A. (1958) In: Heim, R. & Wasson, G. R., Substances S 200-S 203, S 206, S 208, S 213-S 218 ed., Les champignons hallucinogenes du Mexique, and S 220-S 222 are isomers or congeners of LSD. pp. 268-271, Museum national d'Histoire natu- A number of these are much less potent than LSD in relle, Paris (Etude pharmacologique de la hallucinogenic effect or are not hallucinogenic at all psilocybine) (compounds S 203, S 213, S 216, S 217, S 220 and 306. Cohen, S. (1965) The beyond within. The LSD S 222) and accordingly carry a lesser degree of risk story. Atheneum, New York than LSD. None of these weak hallucinogens has 307. Cohen, S. & Ditman, K. S. (1963) Arch. gen. been abused. Other compounds are all sufficiently Psychiat., 8, 475 (Prolonged adverse reactions to potent to make it likely that they would be abused if lysergic acid diethylamide) 308.
    [Show full text]
  • Risk Assessment of Argyreia Nervosa
    Risk assessment of Argyreia nervosa RIVM letter report 2019-0210 W. Chen | L. de Wit-Bos Risk assessment of Argyreia nervosa RIVM letter report 2019-0210 W. Chen | L. de Wit-Bos RIVM letter report 2019-0210 Colophon © RIVM 2020 Parts of this publication may be reproduced, provided acknowledgement is given to the: National Institute for Public Health and the Environment, and the title and year of publication are cited. DOI 10.21945/RIVM-2019-0210 W. Chen (author), RIVM L. de Wit-Bos (author), RIVM Contact: Lianne de Wit Department of Food Safety (VVH) [email protected] This investigation was performed by order of NVWA, within the framework of 9.4.46 Published by: National Institute for Public Health and the Environment, RIVM P.O. Box1 | 3720 BA Bilthoven The Netherlands www.rivm.nl/en Page 2 of 42 RIVM letter report 2019-0210 Synopsis Risk assessment of Argyreia nervosa In the Netherlands, seeds from the plant Hawaiian Baby Woodrose (Argyreia nervosa) are being sold as a so-called ‘legal high’ in smart shops and by internet retailers. The use of these seeds is unsafe. They can cause hallucinogenic effects, nausea, vomiting, elevated heart rate, elevated blood pressure, (severe) fatigue and lethargy. These health effects can occur even when the seeds are consumed at the recommended dose. This is the conclusion of a risk assessment performed by RIVM. Hawaiian Baby Woodrose seeds are sold as raw seeds or in capsules. The raw seeds can be eaten as such, or after being crushed and dissolved in liquid (generally hot water).
    [Show full text]
  • Hallucinogens: an Update
    National Institute on Drug Abuse RESEARCH MONOGRAPH SERIES Hallucinogens: An Update 146 U.S. Department of Health and Human Services • Public Health Service • National Institutes of Health Hallucinogens: An Update Editors: Geraline C. Lin, Ph.D. National Institute on Drug Abuse Richard A. Glennon, Ph.D. Virginia Commonwealth University NIDA Research Monograph 146 1994 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 ACKNOWLEDGEMENT This monograph is based on the papers from a technical review on “Hallucinogens: An Update” held on July 13-14, 1992. The review meeting was sponsored by the National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other material in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors. Citation of the source is appreciated. Opinions expressed in this volume are those of the authors and do not necessarily reflect the opinions or official policy of the National Institute on Drug Abuse or any other part of the U.S. Department of Health and Human Services. The U.S. Government does not endorse or favor any specific commercial product or company.
    [Show full text]
  • Update of the Generic Definition for Tryptamines
    ACMD Advisory Council on the Misuse of Drugs Chair: Professor Les Iversen Secretary: Zahi Sulaiman 2nd Floor (NW), Seacole Building 2 Marsham Street London SW1P 4DF Tel: 020 7035 1121 [email protected] Norman Baker MP, Minister for Crime Prevention Home Office 2 Marsham Street London SW1P 4DF 10 June 2014 Dear Minister, In December 2013, you commissioned the ACMD to begin a regular review of generic definitions under the Misuse of Drugs Act 1971, with the aim of capturing emerging new psychoactive substances. These drugs are variants of controlled drugs and fall outside the existing scope of the Misuse of Drugs Act 1971. The ACMD has considered evidence available on tryptamines in the context of the Misuse of Drugs Act 1971 and I enclose the Advisory Council’s advice and an expanded definition for tryptamine compounds with this letter. The ACMD’s NPS Committee has firstly reviewed previous research and existing controls to identify those tryptamines now seen to evade the existing controls. The ACMD has also reviewed data provided by the Home Office’s early warning systems and networks, clinical toxicology, prevalence and neuropharmacology in arriving at the expanded generic definition. This expanded generic definition will bring drugs such as alpha-methyltryptamine (AMT) as well as 5-MeO-DALT within the scope of the Misuse of Drugs Act 1971. These are highly potent hallucinogens which act on the 5HT2A receptor, in the same way as LSD. The ACMD therefore recommends that the tryptamines covered by the proposed expanded generic definition in this report, are controlled under the Misuse of Drugs Act (1971) as Class A substances.
    [Show full text]
  • Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans
    molecules Review Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans Paul Cumming 1,2,* , Milan Scheidegger 3 , Dario Dornbierer 3, Mikael Palner 4,5,6 , Boris B. Quednow 3,7 and Chantal Martin-Soelch 8 1 Department of Nuclear Medicine, Bern University Hospital, CH-3010 Bern, Switzerland 2 School of Psychology and Counselling, Queensland University of Technology, Brisbane 4059, Australia 3 Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital of the University of Zurich, CH-8032 Zurich, Switzerland; [email protected] (M.S.); [email protected] (D.D.); [email protected] (B.B.Q.) 4 Odense Department of Clinical Research, University of Southern Denmark, DK-5000 Odense, Denmark; [email protected] 5 Department of Nuclear Medicine, Odense University Hospital, DK-5000 Odense, Denmark 6 Neurobiology Research Unit, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark 7 Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, CH-8058 Zurich, Switzerland 8 Department of Psychology, University of Fribourg, CH-1700 Fribourg, Switzerland; [email protected] * Correspondence: [email protected] or [email protected] Abstract: Hallucinogens are a loosely defined group of compounds including LSD, N,N- dimethyltryptamines, mescaline, psilocybin/psilocin, and 2,5-dimethoxy-4-methamphetamine (DOM), Citation: Cumming, P.; Scheidegger, which can evoke intense visual and emotional experiences. We are witnessing a renaissance of re- M.; Dornbierer, D.; Palner, M.; search interest in hallucinogens, driven by increasing awareness of their psychotherapeutic potential. Quednow, B.B.; Martin-Soelch, C. As such, we now present a narrative review of the literature on hallucinogen binding in vitro and Molecular and Functional Imaging ex vivo, and the various molecular imaging studies with positron emission tomography (PET) or Studies of Psychedelic Drug Action in single photon emission computer tomography (SPECT).
    [Show full text]
  • Anesthetics; Drugs of Abuse & Withdrawal
    Anesthetics; Drugs of Abuse & Withdrawal Kurt Kleinschmidt, MD, FACEP, FACMT Professor of Emergency Medicine Section Chief and Program Director Medical Toxicology UT Southwestern Medical Center Much Thanks To… Sean M. Bryant, MD Associate Professor Cook County Hospital (Stroger) Department of Emergency Medicine Assistant Fellowship Director: Toxikon Consortium Associate Medical Director Illinois Poison Center Overview Anesthetics – Local – Inhalational – NM Blockers & Malignant Hyperthermia Drugs of Abuse (Pearls) Withdrawal History 1904-Procaine (short Duration of Action) 1925 (dibucaine) & 1928 (tetracaine) → potent, long acting 1943-lidocaine 1956-mepivacaine, 1959-prilocaine 1963-bupivacaine, 1971-etidocaine, 1996-ropivacaine Lipophili Intermediate Amine Substituents c Group Esters Structure 2 Distinct Groups 1) Amino Esters Amides 2) Amino Amides Local Anesthetics Toxic Reactions • Few & iatrogenic • Blood vessel administration or toxic dose AMIDES have largely replaced ESTERS • Increased stability • Relative absence of hypersensitivity reactions – ESTER hydrolysis = PABA (cross sensitivity) – AMIDES = Multidose preps → methylparabens • Chemically related to PABA with rare allergic reactions Local Anesthetics Mode of Action • Reversible & Predictable Binding • Within membrane-bound sodium channels of conducting tissue (cytoplasmic side of membrane) → Failure to form/propagate action potentials (Small-diam. fibersBLOCKADE carrying pain/temp sensation) Pain fibers - higher firing rate & longer AP → • ↑Sodium susceptible Channelto local
    [Show full text]
  • Clozapine: Selective Labeling of Sites Resembling 5HT6 Serotonin Receptors May Reflect Psychoactive Profile
    Clozapine: Selective Labeling of Sites Resembling 5HT6 Serotonin Receptors May Reflect Psychoactive Profile Charles E. Glatt, Adele M. Snowman, David R. Sibley, and Solomon H. Snyder Departments of Neuroscience, Pharmacology, and Molecular Sciences, and Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A., and Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, U.S.A. ABSTRACT Background: Clozapine, the classic atypical neuroleptic, receptors consistent with the drug's anticholinergic exerts therapeutic actions in schizophrenic patients un- actions. The drug competition profile of the second responsive to most neuroleptics. Clozapine interacts with site most closely resembles 5HT6 serotonin recep- numerous neurotransmitter receptors, and selective ac- tors, though serotonin itself displays low affinity. tions at novel subtypes of dopamine and serotonin re- [3H]Clozapine binding levels are similar in all brain ceptors have been proposed to explain clozapine's regions examined with no concentration in the cor- unique psychotropic effects. To identify sites with which pus striatum. clozapine preferentially interacts in a therapeutic setting, Conclusions: Besides muscarinic receptors, clozapine we have characterized clozapine binding to brain mem- primarily labels sites with properties resembling 5HT6 branes. serotonin receptors. If this is also the site with which Materials and Methods: [3H]Clozapine binding was clozapine principally interacts in intact human brain, it examined in rat brain membranes as well as cloned- may account for the unique beneficial actions of cloza- expressed 5-HT6 serotonin receptors. pine and other atypical neuroleptics, and provide a mo- Results: [3H]Clozapine binds with low nanomolar lecular target for developing new, safer, and more effec- affinity to two distinct sites.
    [Show full text]
  • Patent Office
    Patented Oct. 3, 1944 2,359,688 UNITED STATES PATENT OFFICE 2,359,688 HYDRAZIDES OF DIHYDRO LYSERGIC ACID AND DEHYDRO SOLYSERGIC ACID AND A PROCESS FOR THER MANUEFACTURE Arthur Stoll and Albert Hofmann, Basel, Switzer land, assignors to Sandoz. Ltd., . Fribourg, Switzerland, a corporation of Switzerland No Drawing. Application May 4, 1942, Serial No. 44,754. In Switzerland May 13, 1941 9 Claims. (C. 260-236) The present invention relates to hydrazides of active dihydro isolysergic acid hydrazide is ob dihydro lysergic and dihydro isolysergic acids tained; by using as starting material dihydroly which are valuable products for the manufacture sergic- or isolysergic acid esters respectively, the of alkaloids of the ergot type and to a process same result will be reached. for their manufacture. Besides the aforesaid advantage consisting in It is known that the natural ergot alkaloids on that during the hydrazine treatment no racemisa treatment with hydrazine or hydrazine hydrate tion and isomerization takes place, a further ad become split, whereby as a component of all ergot vantage will be obtained insofar as the yield of alkaloids the lysergic acid can be isolated in form hydrazide increases to 90 to 100% when hydro Of racemic isoly Sergic hydrazide (see U. S. Patent 0. genated alkaloids are used, instead of a yield of No. 2,090,429). This racemic isolysergic acid hy only 70-80% when natural alkaloids are subject drazide is a suitable starting product, for example, ed to the treatment. The treatment of dihydro for the Synthesis of ergobasine, the highly utero derivatives of the lysergic acid with hydrazine active natural ergot alkaloid, and of its homo or hydrazine hydrate is carried out by dissolving logues and derivatives as well as for the syn 15 the starting material in hydrazine or hydrazine thesis of other acid amides of lysergic acid (see hydrate and boiling the solution during e.
    [Show full text]
  • Diversification of Ergot Alkaloids in Natural and Modified Fungi
    Toxins 2015, 7, 201-218; doi:10.3390/toxins7010201 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Diversification of Ergot Alkaloids in Natural and Modified Fungi Sarah L. Robinson and Daniel G. Panaccione * Division of Plant and Soil Sciences, West Virginia University, Morgantown, WV 26506, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-304-293-8819; Fax: +1-304-293-2960. Academic Editor: Christopher L. Schardl Received: 21 November 2014 / Accepted: 14 January 2015 / Published: 20 January 2015 Abstract: Several fungi in two different families––the Clavicipitaceae and the Trichocomaceae––produce different profiles of ergot alkaloids, many of which are important in agriculture and medicine. All ergot alkaloid producers share early steps before their pathways diverge to produce different end products. EasA, an oxidoreductase of the old yellow enzyme class, has alternate activities in different fungi resulting in branching of the pathway. Enzymes beyond the branch point differ among lineages. In the Clavicipitaceae, diversity is generated by the presence or absence and activities of lysergyl peptide synthetases, which interact to make lysergic acid amides and ergopeptines. The range of ergopeptines in a fungus may be controlled by the presence of multiple peptide synthetases as well as by the specificity of individual peptide synthetase domains. In the Trichocomaceae, diversity is generated by the presence or absence of the prenyl transferase encoded by easL (also called fgaPT1). Moreover, relaxed specificity of EasL appears to contribute to ergot alkaloid diversification. The profile of ergot alkaloids observed within a fungus also is affected by a delayed flux of intermediates through the pathway, which results in an accumulation of intermediates or early pathway byproducts to concentrations comparable to that of the pathway end product.
    [Show full text]
  • The Structure of Dimethylallyl Tryptophan Synthase Reveals a Common Architecture of Aromatic Prenyltransferases in Fungi and Bacteria
    The structure of dimethylallyl tryptophan synthase reveals a common architecture of aromatic prenyltransferases in fungi and bacteria Ute Metzgera,1, Christoph Schallb,1, Georg Zocherb, Inge Unso¨ lda, Edyta Stecc, Shu-Ming Lic, Lutz Heidea,2, and Thilo Stehleb,d aPharmazeutisches Institut, Universita¨t Tu¨ bingen, 72076 Tu¨bingen, Germany; bInterfakulta¨res Institut fu¨r Biochemie, Universita¨t Tu¨ bingen, 72076 Tu¨bingen, Germany; cInstitut fu¨r Pharmazeutische Biologie, Universita¨t Marburg, 35037 Marburg, Germany; and dDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232 Edited by Arnold L. Demain, Drew University, Madison, NJ, and approved July 9, 2009 (received for review May 5, 2009) Ergot alkaloids are toxins and important pharmaceuticals that are farnesyl diphosphate synthase (11, 12), DMATS does not require produced biotechnologically on an industrial scale. The first com- magnesium or other divalent cations for its enzymatic activity, mitted step of ergot alkaloid biosynthesis is catalyzed by dimethy- although addition of 4 mM CaCl2 moderately increases its reaction lallyl tryptophan synthase (DMATS; EC 2.5.1.34). Orthologs of velocity (10). The structural gene coding for DMATS in Claviceps, DMATS are found in many fungal genomes. We report here the termed dmaW, was identified by Tsai et al. (13). A similar gene, x-ray structure of DMATS, determined at a resolution of 1.76 Å. A fgaPT2, exists in the biosynthetic gene cluster of fumigaclavine, in complex of DMATS from Aspergillus fumigatus with its aromatic the genome sequence of A. fumigatus. Expression of the DMATS substrate L-tryptophan and with an analogue of its isoprenoid sequence from A.
    [Show full text]